Yan Cai

Yan Cai


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 1998 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
RHRichard L. Henry
Richard L. Henry
PGpeter gibson
peter gibson
KCKellie Carty
Kellie Carty
YCYan Cai
Yan Cai
JFJ. Lynn Francis
J. Lynn Francis

4 August 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
KZKai Zhao
Kai Zhao
ZZZhengliang Zhang
Zhengliang Zhang
YLYing Liang
Ying Liang
YWYan Wang
Yan Wang
YCYan Cai
Yan Cai
Purpose: This study aimed to investigate the prevalence of antimicrobial de-escalation (ADE) strategy and assess its effect on 14-day mortality among intensive care unit patients. Methods: A single-center retrospective cohort study was conducted on patients admitted to the intensive care unit (ICU) with infectious diseases between January 2018 and December 2020. Patients were stratified into three groups based on the initial treatment regimen within 5 days of antimicrobial administration: ADE, No Change, and Other Change. Confounders between groups were screened using one-way ANOVA and Chi-square analysis. Univariate and multivariate analyses were performed to identify risk factors for 14-day mortality. Potential confounders were balanced using propensity score inverse probability of treatment weighting (IPTW), followed by multivariate logistic regression analysis to evaluate the effect of ADE strategy on 14-day mortality. Results: A total of 473 patients met the inclusion criteria, with 53 (11.2%) in the ADE group, 173 (36.6%) in the No Change group, and 247 (52.2%) in the Other Change group. The 14-day mortality rates in the three groups were 9.4%, 11.6%, and 21.9%, respectively. After IPTW, the adjusted odds ratio for 14-day mortality comparing No Change with ADE was 1.557 (95% CI 1.078–2.247, P = 0.0181) while comparing Other Change with ADE was 1.282(95% CI 0.884–1.873, P = 0.1874). Conclusion: The prevalence of ADE strategy was low among intensive care unit patients. The ADE strategy demonstrated a protective effect or no adverse effect on 14-day mortality compared to the No Change or Other Change strategies, respectively. These findings provide evidence supporting the implementation of the ADE strategy in ICU patients.

20 March 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
WBWei Bu
Wei Bu
CWChengyu Wang
Chengyu Wang
YWYuan Wu
Yuan Wu
PZPeng Zhang
Peng Zhang
NZNengfang Zhang
Nengfang Zhang
YCYan Cai
Yan Cai
Despite the widespread use of colistin sulfate (CS) in clinical settings in China over recent years, supported by several studies demonstrating its clinical efficacy, there remains a lack of comparative data on the efficacy and safety of polymyxin B sulfate (PMB) versus CS, specifically for carbapenem-resistant Acinetobacter baumannii (CRAB)-caused nosocomial pneumonia. To compare the efficacy and safety of PMB and CS in intensive care unit (ICU) patients with nosocomial pneumonia caused by CRAB. We conducted a multicenter retrospective cohort study, including patients diagnosed with CRAB-caused nosocomial pneumonia and treated with intravenous PMB or CS in the ICU of the study hospitals between January 1, 2020, and June 30, 2024. Propensity score matching (PSM) was employed to adjust for potential baseline confounders between cohorts. Multivariate logistic regression analysis and Cox logistic regression analyses were performed to identify for factors potentially influencing the clinical outcomes and adverse events. Following matching, a total of 190 patients were analyzed. There was no statistical significance in the rates of clinical success, microbiological eradication and 28-day mortality between the PMB and CS cohorts. While the incidence of acute kidney injury (AKI) and hepatotoxicity were comparable in both cohorts, but dermal toxicity was significantly higher in patients receiving PMB compared to those receiving CS (18.9% vs. 0%, P < 0.05). Among all the patients, hypertension, baseline renal insufficiency, usage of vasoactive drugs and in combination with three or more antibiotics were independent risk factors associated with AKI; while age, duration of polymyxins ≤ 7 days and Sequential Organ Failure Assessment (SOFA) score were risk factors associated with 28-day all-cause mortality. This study establishes that PMB and CS have similar efficacy in treating CRAB induced nosocomial pneumonia in the ICU settings. The incidence of AKI and hepatotoxicity of both polymyxins are comparable for both polymyxins, although PMB is associated with a significantly higher incidence of skin toxicity. Ensuring adequate therapy duration is key to better outcomes in the treatment of CRAB-induced nosocomial pneumonia in ICU patients, regardless of the type of polymyxins.

10 June 2021 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
PDF file
YCYan Cai
Yan Cai
MZMinggang Zhang
Minggang Zhang
YWYan Wang
Yan Wang
NWNa Wang
Na Wang
LZLi Zhang
Li Zhang
KZKanghuai Zhang
Kanghuai Zhang

7 November 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
WBWei Bu
Wei Bu
XWXinjing Wu
Xinjing Wu
CWChengyu Wang
Chengyu Wang
YCYan Cai
Yan Cai
Background: Severe adverse drug reactions (SADRs) pose significant challenges to pharmacotherapy. Machine learning (ML) models hold promise in providing reliable solutions for predicting SADRs. This study is designed to pinpoint the independent risk factors contributing to SADRs through the application of ML techniques, thus constructing a predictive model for SADRs applicable in real-world clinical settings. Methods: This retrospective dual-center cohort study analyzed adverse drug reaction (ADR) cases reported in two Chinese tertiary medical centers from 2014 to 2022. Per the World Health Organization - Uppsala Monitoring Centre severity criteria, cases were classified as SADRs or common ADRs. Independent predictors were identified via univariate and multivariate logistic regression (LR). A random partitioning of the data set resulted in a 75% training set and a 25% test set. The performance of three ML algorithms, including LR, Random Forest and Gradient Boosting Machine, was compared. A nomogram was constructed, model performance was measured by the area under the receiver operating characteristic curve (AUC), concordance index (C index), Hosmer-Lemeshow test (H-L test), Decision Curve Analysis (DCA), and Clinical Impact Curve (CIC). Results: A total of 508 SADRs were identified. The AUC values of LR model demonstrates the highest predictability among the three ML models. The AUC was 0.707 in the test set and the AUC in the training set was 0.689. A nomogram was established based on the LR model and evaluated. The C-index was 0.714 in the test set and the AUC in the training set was 0.713; The H-L test produced a chi-square value of 9.769 ( p = 0.369), indicating good calibration. The DCA and CIC verify that the LR model possesses significant predictive value. According to the LR model, there were 20 predictors, including age ≥54 years, concurrent diseases ≥3, cardiac insufficiency, hemorrhagic disorders, active malignancies, cerebral infarction, bone fractures, anti-infectives, cytotoxic antineoplastics, proton pump inhibitors, antiepileptics, anticoagulants, diagnostic agents, arterial administration. Conclusion: This study established a predictive nomogram for SADRs based on LR through comparative analysis of three ML approaches. The developed nomogram enables clinically meaningful risk stratification for SADRs, facilitating prophylactic surveillance of high-risk populations.

1 April 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
WBWei Bu
Wei Bu
CWChengyu Wang
Chengyu Wang
YWYuan Wu
Yuan Wu
PZPeng Zhang
Peng Zhang
NZNengfang Zhang
Nengfang Zhang
YCYan Cai
Yan Cai